NCT01946412View on ClinicalTrials.gov

Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Cystic Fibrosis

Interventions

DRUG

Ivacaftor

Trial Locations (16)

Unknown

Birmingham

Denver

Atlanta

Indianapolis

Boston

Grand Rapids

Minneapolis

Kansas City

Omaha

Salt Lake City

Richmond

Seattle

Vancouver

Edinburgh

Liverpool

London

All Listed Sponsors

collaborator

Cystic Fibrosis Foundation

OTHER

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT01946412 - Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation | Biotech Hunter | Biotech Hunter